That’s all folks!
Really, that’s all.
Okay, there’s more, but I suppose we all know that the result of the EU Referendum has without a doubt cast a shadow over any other news, but even then, life goes on.
- BREXIT – United Kindgdom votes to leave the European Union: On Friday June 24, 2016, many people (including the Lady) woke up to the news that majority in the UK had voted in favour of Brexit. Well, majority in London, Scotland and Northern Ireland voted against Brexit. The lady spent the entire day on this BBC webpage following the developments. How does this affect IP you ask. Well, if you are an ardent reader of the Manor, we covered that in previous editions of our Saturday Reads. Nevertheless, the links in our most recent Saturday Reads pretty much sums up all you need to know about the impact of Brexit on the IP community. You can catch up on all of that here.
- Innovation Prize for Africa Announces 2016 Winners: Big winners from this year’s edition of the Innovation Prize for Africa (IPA) awards are Dr Valentin Agon for his ground-breaking anti-malarial drug (Api-Palu) made from natural plant extracts; Dr Imogen Wright for her software aimed at testing for HIV drug-resistance medication; and Dr Eddy Agbo for developing a cheap, simple urine test for malaria. More on that here.
Scientists create new bio-ink for 3D printing: Scientists from the University of Bristol have found a new bio-ink for 3D printing with stem cells that allows printing of living tissue known as bio-printing. The new bio-ink contains two different polymer components: a natural polymer extracted from seaweed and a sacrificial synthetic polymer used in the medical industry. Read more here. The Lady may or may not have revealed her vested interests in this emerging field of technology in this post.
India may lose its position as the ‘pharmacy of the world’: Médecins Sans Frontières (MSF) has warned that if India adopts the proposals contained in the Regional Comprehensive Economic Partnership agreement (RCEP), the country will not remain ‘pharmacy of the developing world’. The RCEP, which has been likened to the infamous US-led Trans-Pacific Partnership agreement, is a regional trade agreement being negotiated between the 10 ASEAN (Association of Southeast Asian Nations) countries currently in Auckland. More on that here.